Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bunazosin vs Atropine vs Combination for Childhood Myopia
jRCTs031230616Completed
- Sponsor
- Tsubota Laboratory
- Start
- Mar 2024
- Modality
- Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial in myopia comparing 0.01% bunazosin monotherapy, 0.025% atropine monotherapy and 0.01% bunazosin + 0.025% atropine combination (3 arms). Primary endpoints: Safety assessment - corrected visual acuity, Safety assessment - intraocular pressure and 7 more. Started Mar 2024; status: completed.
02
Drugs
bunazosinatropine
03
Conditions
myopia
Beyond the preview
Go deeper on jRCTs031230616.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs031230616.